The FDA removes the contraindication for use of Bracco Diagnostics Inc.'s LUMASON® (sulfur hexafluoride lipid-type A microspheres) for injectable suspension, for intravenous use or intravesical use, in patients with cardiac shunts
UTEX B 331 Ulothrix confervicola | UTEX Culture Collection of Algae
Bracco LUMASON® | Safety
LUPKYNIS (voclosporin) for the Treatment of Lupus Nephritis, US